- Parties: The plaintiffs were Novartis AG and Novartis Pharmaceuticals Canada Inc. The defendant was Pharmascience Inc.

- Subject Matter: This action involved the Patented Medicines (NOC) Regulations.

- Date: The action was voluntarily discontinued on August 23, 2024. The discontinuance was filed by the Plaintiff with the consent of the Defendant. No further proceedings are recorded, and the discontinuance appears to be final unless the Plaintiff revives or reinitiates proceedings through a new action.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.